08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Source Url: https://www.jdsupra.com/legalnews/fda-signals-a-deliberative-approach-to-46336/
Related
The California Consumer Privacy Act of 2018 (CCPA) will take effect on January 1, 2020, and hedge fu...
Read More >
CBS and Viacom are back together again. The deal to reunite the former partners, which closed late y...
Read More >
First, the good news: The Equal Employment Opportunity Commission (EEOC) has provided notice that it...
Read More >
The Equal Pay Act of 1963 (EPA) has recently been in the press due to a lawsuit filed by 28 players ...
Read More >
Many still recall the SARS outbreak, which caused a slowdown in the economy and a plunge in the stoc...
Read More >
For some time we have been following with interest the case of Bresco Electrical Services Ltd (in li...
Read More >